Skip to content
Sharon King’s daughter Taylor was a happy surprise. And up until Taylor was in the first grade, she was developing normally. But the first […]
Bespoke Gene Therapy Consortium gives rare disease biotechs a path forward Read More »
Artificial intelligence (AI) is revolutionizing drug discovery, paving the way for groundbreaking treatments. In fact, a recent study found that biotech companies using AI
How does AI drug discovery really work? A new paper reveals the process Read More »
A year ago, the sentiment for the industry was extremely low. In 2023, the biotech stock indices were sliding to potential new lows, levels
5 reasons for investor optimism at BIO-Europe Spring 2024 Read More »
Editor’s Note: On Wednesday, May 1, 2024, the California Supreme Court said it will consider Gilead’s request for summary dismissal, agreeing with BIO’s March
BIO opposes lawsuit that would penalize drugmaker for innovating too slowly Read More »
March shines a spotlight on patients living with bleeding disorders, and their families and caregivers. Bleeding Disorders Awareness Month raises awareness of conditions like
Let’s start a conversation about Bleeding Disorders Awareness Month Read More »
The Inflation Reduction Act (IRA) is expected to have broad negative impacts on patients, most notably through less access to future cures and treatments.
Heart disease patients and the IRA’s misguided incentives Read More »
March is Autoimmune Awareness Month, so Bio.News has partnered with The Autoimmune Association to talk about the top five things you need to know
Top 5 things to know during Autoimmune Disease Awareness Month Read More »
The COVID-19 pandemic laid bare the vulnerabilities of global supply chains, especially in the biopharmaceutical sector. “Nobody ever could have envisioned a global pandemic
Why building America’s biomanufacturing sector is critical for America’s security Read More »
The Colorado Prescription Drug Affordability Board (PDAB) has many patients, patient advocacy groups, and bioscience organizations in the state worried. As one of the
Colorado PDAB could limit patient access to medicines Read More »
President Biden’s executive order announced March 18 calls for coordinated federal action and an investment of $200 million to promote research into women’s health,
Biden’s executive order on women’s health research includes $200M for NIH Read More »
